S&P assigns ‘A’ rating to Edward-Elmhurst Healthcare’s bonds

S&P Global Ratings assigned an “A” rating to Naperville, Ill.-based Edward-Elmhurst Healthcare’s series 2016A bonds.

Advertisement

S&P also affirmed the “A” underlying rating on EEH’s series 2008A and 2008B-1, 2008B-2, 2008C and 2009A bonds.

“The ratings reflect our view of EEH’s improved operational performance, stable leadership team and respectable average age of plant,” said S&P analyst Brian Williamson.

The outlook is stable, reflecting S&P’s expectation that EEH will be able to maintain its strong financial profile despite budgeting for softer operations in fiscal year 2017.

More articles on healthcare finance:
Paramedics Plus, ETMC partner with EMS|MC for billing
RCM tip of the day: Update proprietary forms with new ICD-10 codes
Seattle firm receives $250M to co-develop hospitals, nursing homes in China 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.